Detalles de la búsqueda
1.
Deep learning-based detection and quantification of brain metastases on black-blood imaging can provide treatment suggestions: a clinical cohort study.
Eur Radiol
; 34(3): 2062-2071, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-37658885
2.
Vessel size and perfusion-derived vascular habitat refines prediction of treatment failure to bevacizumab in recurrent glioblastomas: validation in a prospective cohort.
Eur Radiol
; 33(6): 4475-4485, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-36242633
3.
Radiomics-based prediction model for outcomes of PD-1/PD-L1 immunotherapy in metastatic urothelial carcinoma.
Eur Radiol
; 30(10): 5392-5403, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32394281
4.
How Cancer Patients Perceive Clinical Trials (CTs) in the Era of CTs: Current Perception and Its Differences Between Common and Rare Cancers.
J Cancer Educ
; 35(3): 545-556, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30820925
5.
Clinical course of patients with renal cell carcinoma or urothelial carcinoma who had stable disease as an initial response to a PD-1 or PD-L1 inhibitor.
Asia Pac J Clin Oncol
; 18(4): 371-377, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-34219393
6.
Clinical implications of the tumor microenvironment using multiplexed immunohistochemistry in patients with advanced or metastatic renal cell carcinoma treated with nivolumab plus ipilimumab.
Front Oncol
; 12: 969569, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36237314
7.
Use of Gemcitabine plus Carboplatin is Associated with Poor Outcomes in Urothelial Carcinoma Patients with Chronic Kidney Disease Stage 4-5.
Cancer Res Treat
; 53(4): 1166-1173, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-33677847
8.
Hyperprogressive Disease in Patients With Urothelial Carcinoma or Renal Cell Carcinoma Treated With PD-1/PD-L1 Inhibitors.
Clin Genitourin Cancer
; 18(2): e122-e133, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31837940
9.
Impact of clinicopathologic features on leptomeningeal metastasis from lung adenocarcinoma and treatment efficacy with epidermal growth factor receptor tyrosine kinase inhibitor.
Thorac Cancer
; 11(2): 436-442, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31910497
10.
Efficacy, safety, and resistance profile of osimertinib in T790M mutation-positive non-small cell lung cancer in real-world practice.
PLoS One
; 14(1): e0210225, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30625213
11.
The continued EGFR-TKI with cytotoxic chemotherapy at progression-poison or medicine?
Transl Lung Cancer Res
; 7(Suppl 2): S176-S178, 2018 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-29780711
12.
Prognostic implications of tumor extent in early-stage diffuse large B-cell lymphoma.
Int J Hematol
; 97(2): 232-9, 2013 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-23359300
13.
Cross-sectional study of imatinib plasma trough levels in patients with advanced gastrointestinal stromal tumors: impact of gastrointestinal resection on exposure to imatinib.
J Clin Oncol
; 28(9): 1554-9, 2010 Mar 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-20177019
14.
Angiosarcoma of the retroperitoneum: report on a patient treated with sunitinib.
Sarcoma
; 2009: 360875, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-19478954
Resultados
1 -
14
de 14
1
Próxima >
>>